Patents Assigned to DexCom, Inc.
-
Publication number: 20260288926Abstract: Measurements of biometric information of a user are obtained over time, such as blood glucose measurements. These biometric measurements are typically obtained by a wearable biometric information monitoring device being worn by the user. These biometric measurements are used by various different systems, such as a computing device of the user or a biometric information monitoring platform that receives biometric measurements from multiple different users. The biometric measurements are used for various security aspects, such as one or more of part of multi-factor authentication of the user, generating security keys (e.g., connection keys, encryption keys), identifying biometric measurements associated with different user identifiers but the same use, and protecting biometric measurements so as to be retrievable only by a recipient associated with an additional computing device, and so forth.Type: ApplicationFiled: May 28, 2026Publication date: September 24, 2026Applicant: Dexcom, Inc.Inventors: Thomas Hall, Andrew Attila Pal, Matthew Lawrence Johnson, Issa S. Salameh, Christopher Efigenio, Michael Tyler
-
Publication number: 20260272300Abstract: The present disclosure relates to systems and methods for activating a circuit of an implant device. Consistent with one implementation, an implant device is provided with a sensor including a working electrode (WE) and a counter electrode (CE). The sensor may be configured to generate a first current at the CE when the implant device is implanted in a body of a subject. A sensing circuit may also be provided that is electrically coupled to the WE of the sensor. The sensing circuit may be activated based on the first current and utilize the sensor to measure one or more parameters of an individual or other subject.Type: ApplicationFiled: May 11, 2026Publication date: September 17, 2026Applicants: Dexcom, Inc., Verily Life Sciences LLCInventors: Alireza DASTGHEIB, Johan VANDERHAEGEN
-
Patent number: 12733866Abstract: Techniques for generating a user interface view including sensor data representative of analyte levels of a host are disclosed. In certain embodiments, a technique includes accessing sensor data including a plurality of analyte readings of the host during a plurality of time periods, wherein each analyte reading is indicative of an analyte level of the host at a respective time. The technique further includes generating a first user interface (UI) view comprising one or more UI elements based on the plurality of analyte levels of the host, and, in response to receiving a user selection of a pregnancy mode, automatically modifying a parameter of at least one UI element included in the one or more UI elements to reflect a pregnancy-specific parameter. The technique further includes generating a second UI view based on the plurality of analyte levels of the host and the pregnancy-specific parameter.Type: GrantFiled: November 16, 2023Date of Patent: September 15, 2026Assignee: Dexcom, Inc.Inventors: Charles R. Stroyeck, Sonya Frangopoulos, Douglas S. Kanter, Afshan Kleinhanzl, Shelbi Lyn Howard, Joann Nhu, Maren Bean, Kazanna C. Hames, Lindsey Franklin
-
Patent number: 12733842Abstract: Systems and methods described provide dynamic and intelligent ways to change the required level of user interaction during use of a monitoring device. The systems and methods generally relate to real time switching between a first or initial mode of user interaction and a second or new mode of user interaction. In some cases, the switching will be automatic and transparent to the user, and in other cases user notification may occur. The mode switching generally affects the user's interaction with the device, and not just internal processing. The mode switching may relate to calibration modes, data transmission modes, control modes, or the like.Type: GrantFiled: March 3, 2016Date of Patent: September 15, 2026Assignee: Dexcom, Inc.Inventors: Naresh C. Bhavaraju, Michael A. Bloom, Leif N. Bowman, Alexandra Lynn Carlton, Katherine Yerre Koehler, Hari Hampapuram, Jonathan Hughes, Lauren Hruby Jepson, Apurv Ulas Kamath, Anna Leigh Davis, Peter C. Simpson, Stephen J. Vanslyke
-
Patent number: 12727793Abstract: Devices and methods for measuring a concentration of a target analyte in a biological fluid in vivo are provided herein. In some examples, a device includes an indwelling sensor and sensor electronics. The sensor may include a substrate; a first electrode disposed on the substrate; an ionophore disposed on the substrate to selectively transport the target ion to or within the first electrode; and a second electrode disposed on the substrate. The sensor electronics is configured to generate a signal corresponding to an electromotive force which is at least partially based on a potential difference that is generated between the first electrode and the second electrode responsive to the ionophore transporting the target ion to the first electrode.Type: GrantFiled: September 1, 2023Date of Patent: September 8, 2026Assignee: DEXCOM, INC.Inventors: Berta Esteban Fernandez de Avila, Devon M. Headen, Stacy Hunt DuVall, Jiong Zou, Shane Richard Parnell, Nicholas Vincent Apollo, Joshua Ray Windmiller
-
Patent number: 12717961Abstract: A method and system for generating synthetic data is provided. Longitudinal time series data are retrieved, and a neural network is trained to generate synthetic time series data that satisfies a privacy metric based on the longitudinal time series data. The longitudinal time series data are unlabeled and univariate.Type: GrantFiled: September 27, 2023Date of Patent: August 25, 2026Assignee: Dexcom, Inc.Inventor: Josephine Lamp
-
Patent number: 12702361Abstract: Systems and methods for providing sensitive and specific alarms indicative of glycemic condition are provided herein. In an embodiment, a method of processing sensor data by a continuous analyte sensor includes: evaluating sensor data using a first function to determine whether a real time glucose value meets a first threshold; evaluating sensor data using a second function to determine whether a predicted glucose value meets a second threshold; activating a hypoglycemic indicator if either the first threshold is met or if the second threshold is predicted to be met; and providing an output based on the activated hypoglycemic indicator.Type: GrantFiled: March 7, 2023Date of Patent: August 11, 2026Assignee: Dexcom, Inc.Inventors: Hari Hampapuram, Anna Leigh Davis, Naresh C. Bhavaraju, Apurv Ullas Kamath, Claudio Cobelli, Giovanni Sparacino, Andrea Facchinetti, Chiara Zecchin
-
Publication number: 20260224136Abstract: An example continuous glucose monitor includes a printed circuit board (“PCB”) having first and second outer layers and an inner layer; a semiconductor package having a plurality of pins coupled to the first outer layer of the PCB; an electrical contact formed on the second outer layer of the PCB; a trace having a first portion disposed on the first outer layer, a second portion disposed on the inner layer, and a third portion disposed on the second outer layer, the trace having a first end coupled to a first pin of the plurality of pins and a second end coupled to the electrical contact; and an encapsulant disposed around a perimeter of the semiconductor package, the encapsulant covering the plurality of pins, the first portion of the sensor trace, the third portion of the sensor trace, wherein an upper surface of the semiconductor package remains exposed.Type: ApplicationFiled: March 27, 2026Publication date: August 6, 2026Applicants: DexCom, Inc., Verily Life Sciences LLCInventors: Mandy Philippine, Scott Matula, Johan Vanderhaegen, Louis Jung, Nivi Arumugam
-
Patent number: 12697049Abstract: A method for monitoring a blood glucose level of a user is provided. The method includes receiving a time-varying electrical signal from an analyte sensor during a temporal phase of a monitoring session. The method includes selecting a calibration model from a plurality of calibration models, wherein the selected calibration model comprises one or more calibration model parameters. The method includes estimating at least one of the one or more calibration model parameters of the selected calibration model based on at least the time-varying electrical signal during the temporal phase of the monitoring session. The method includes estimating the blood glucose level of the user based on the selected calibration model and using the at least one estimated parameter. An apparatus and non-transitory computer readable medium having similar functionality are also provided.Type: GrantFiled: January 31, 2020Date of Patent: August 4, 2026Assignee: Dexcom, Inc.Inventors: Stephen J. Vanslyke, Giada Acciaroli, Martina Vettoretti, Andrea Facchinetti, Giovanni Sparacino
-
Publication number: 20260207095Abstract: In one embodiment, a continuous analyte sensor having more than one working electrode, and configured to reduce or eliminate crosstalk between the working electrodes. In another embodiment, a continuous analyte sensor having more than one working electrode, and configured so that a membrane system has equal thicknesses over each of the electrodes, despite having differing numbers of layers over each of the electrodes. In another embodiment, a configuration for connecting a continuous analyte sensor to sensor electronics. In another embodiment, methods for forming precise windows in an insulator material on a multi-electrode assembly. In another embodiment, a contact assembly for a continuous analyte sensor having more than one working electrode.Type: ApplicationFiled: March 16, 2026Publication date: July 23, 2026Applicant: DexCom, Inc.Inventors: Peter C. Simpson, Sebastian Bohm, Robert J. Boock, Matthew D. Wightlin, Huashi Zhang
-
Patent number: 12689679Abstract: Techniques and protocols for enhancing wireless communications between an analyte sensor system and one or more other devices are described. Such techniques may include, for example, dynamic adjustment of transmission power when transmitting invitations, transmitting invitations with alternate (or different) payloads during different invitation periods, a reduction of handshake messages (e.g., client characteristic configuration descriptor (CCCD) messaging), etc. The various enhancements described herein may relate to various aspects of wireless communication protocols, including, for example, authentication, connection protocols, invitation message structure and content, device pairing, data transmission, etc.Type: GrantFiled: September 16, 2024Date of Patent: July 21, 2026Assignee: DEXCOM, INC.Inventors: Satish Kumar Kanteti, Jefferson Hu, Ismael V. Jimenez
-
Patent number: 12685465Abstract: In some aspects, an apparatus for a biosensor includes a sensor wire and a rigid member. The rigid member may be coupled to the sensor wire and include a contact surface. The contact surface may be sized to enable a suction head of a robotic placement device to create a vacuum seal on the contact surface for lifting the sensor wire and rigid member.Type: GrantFiled: March 28, 2023Date of Patent: July 21, 2026Assignee: Dexcom, Inc.Inventors: Ohseung Kwon, Xianyan Wang, Timothy Stowe
-
Patent number: 12685466Abstract: Various examples are described for methods for needle alignment for wearable biosensors. One example device includes a housing comprising an upper portion and a lower portion, the housing defining a cavity between the upper portion and the lower portion and configured to be worn on a wearer's skin, wherein: the upper portion defines a first opening extending through the upper portion to the cavity, and the lower portion defines a second opening extending through the lower portion to the cavity, the cavity establishing a substantially unobstructed pathway including the first opening and the second opening to enable an insertion needle to be inserted through the housing; and a needle guide extending into and along a portion of the pathway and aligned with a sensor wire to enable alignment between the insertion needle and the sensor wire.Type: GrantFiled: December 22, 2021Date of Patent: July 21, 2026Assignee: Dexcom, Inc.Inventor: Sean Frick
-
Patent number: 12684494Abstract: Systems, techniques, and devices for performing variable power transmission for a battery-powered device are disclosed. In certain embodiments, the techniques include determining a proximity of the transmitter to a first display device. An output transmission power of the transmitter is determined based on the proximity. Analyte information from an analyte sensor coupled to the transmitter is transmitted to the first display device at the output transmission power.Type: GrantFiled: October 12, 2023Date of Patent: July 14, 2026Assignee: Dexcom, Inc.Inventors: Nathanael Richard Paul, Jorge R. Barreras
-
Patent number: 12683021Abstract: Methods and systems for encouraging interactions with a glucose monitoring system include incrementing a score and/or providing a reward based on a variety of different interactions with the glucose monitoring system. The interactions which improve the score may include initiating or changing displays, downloading data, setting operational parameters and other interactions that are independent of a user's glucose measurements. Encouraging these interactions can enhance success in maintaining healthy glucose concentrations.Type: GrantFiled: December 6, 2019Date of Patent: July 14, 2026Assignee: Dexcom, Inc.Inventors: Apurv Ullas Kamath, Jack Pryor, Alexandra Lynn Carlton, Kristin Koenekamp Cote, Leif N. Bowman, Michael Robert Mensinger
-
Publication number: 20260192048Abstract: A continuous glucose monitor (CGM)-driven basal insulin titration system and method for patients with Type 2 Diabetes can be adapted to the needs and concerns of subjects just starting on basal insulin therapy. The method uses as inputs historical CGM data, basal insulin dose information, reports of hypoglycemia, and past recommendations and generates an adjusted insulin dose along with a report advising whether to continue the titration process, or to stop. The method can generate a new recommendation on a regular basis (e.g., each day) until it determines an adequate, consistent dose size.Type: ApplicationFiled: March 3, 2026Publication date: July 9, 2026Applicant: Dexcom, Inc.Inventors: Stephen D. Patek, Matthew S. Gerber, Enrique Campos-Nanez, Thibault Gautier, Leah Ziegler
-
Patent number: 12672802Abstract: Systems and methods for wireless communication of analyte information are disclosed. Example embodiments include an analyte sensor system. The analyte sensor system may include an analyte sensor to gather information related to a level of an analyte in a host. The analyte sensor system may include circuitry to transmit and receive wireless signals using a first antenna. The analyte sensor may be coupled to the circuitry before the analyte sensor system is transitioned into an operational state. The analyte sensor system may include a second antenna to receive an input signal from a source external to the analyte sensor system and to transmit a modified signal. The circuitry may use the first antenna to receive the modified signal The analyte sensor system may transition into the operational state in response to the modified signal received using the first antenna.Type: GrantFiled: September 22, 2022Date of Patent: July 7, 2026Assignee: Dexcom, Inc.Inventors: Patrick John Castagna, David A. Keller, Warren Terry
-
Patent number: 12676733Abstract: Techniques for performing application-layer security are disclosed. In certain embodiments, analyte data may be obtained from an analyte sensor operatively coupled to a sensor electronics module of an analyte sensor system. Thereafter, the analyte data may be encrypted, in an application layer of a protocol stack of the sensor electronics module using a session key established between the analyte sensor system and a display device. The encrypted analyte data may then be transmitted to a display device.Type: GrantFiled: February 9, 2024Date of Patent: July 7, 2026Assignee: Dexcom, Inc.Inventors: Jorge R. Barreras, Reinier Sanchez Bao, Ariel Alvarez
-
Patent number: 12672235Abstract: An example sensor interposer employing castellated through-vias formed in a PCB includes a planar substrate defining a plurality of castellated through-vias; a first electrical contact formed on the planar substrate and electrically coupled to a first castellated through-via; a second electrical contact formed on the planar substrate and electrically coupled to a second castellated through-via, the second castellated through-via electrically isolated from the first castellated through-via; and a guard trace formed on the planar substrate, the guard trace having a first portion formed on a first surface of the planar substrate and electrically coupling a third castellated through-via to a fourth castellated through-via, the guard trace having a second portion formed on a second surface of the planar substrate and electrically coupling the third castellated through-via to the fourth castellated through-via, the guard trace formed between the first and second electrical contacts to provide electrical isolation bType: GrantFiled: February 23, 2024Date of Patent: June 30, 2026Assignee: DexCom, Inc.Inventors: Sean Frick, Louis Jung, David Lari
-
Publication number: 20260174363Abstract: The present disclosure relates generally to apparatuses and methods of selectively coating along a length of an elongated body with a coating. In some examples, the elongated body is an insertable analyte sensor portion and the coating comprises one or more anti-inflammatory compounds or tissue response modifiers. One or more additional layers are also disclosed that modulate a release rate or an amount of the one or more anti-inflammatory compounds or tissue response modifiers after implantation in interstitial fluid.Type: ApplicationFiled: September 29, 2025Publication date: June 25, 2026Applicant: Dexcom, Inc.Inventors: Jiong Zou, Shanger Wang, Ted T. Lee, Kristoffer Roy C. Ravana, Florante A. Pineda, Mahender Nath Avula, Saral Kalanadhabhatla, Joshua Ray Windmiller, Andre Filipe Camargo Silva, Becky L. Clark, Anna C. Harley-Trochimczyk, William D. Davis-Betanzos, Samuel Charles Rogers, Jay Philip Warren, Sean Akio Collignon, Max Walter Akita, Jonathan Kyle Harris